vs
Side-by-side financial comparison of Finwise Bancorp (FINW) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $46.9M, roughly 1.0× Finwise Bancorp). Finwise Bancorp runs the higher net margin — 8.4% vs -4.8%, a 13.1% gap on every dollar of revenue. On growth, Finwise Bancorp posted the faster year-over-year revenue change (121.7% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-28.6M). Over the past eight quarters, Finwise Bancorp's revenue compounded faster (54.3% CAGR vs -20.2%).
Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
FINW vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.9M | $47.7M |
| Net Profit | $3.9M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 11.7% | 14.3% |
| Net Margin | 8.4% | -4.8% |
| Revenue YoY | 121.7% | -47.3% |
| Net Profit YoY | 40.1% | -200.9% |
| EPS (diluted) | $0.27 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $46.9M | $47.7M | ||
| Q3 25 | $36.7M | $122.1M | ||
| Q2 25 | $25.1M | $85.2M | ||
| Q1 25 | $22.1M | $41.1M | ||
| Q4 24 | $21.1M | $90.5M | ||
| Q3 24 | $20.8M | $91.6M | ||
| Q2 24 | $19.8M | $94.4M | ||
| Q1 24 | $19.7M | $74.9M |
| Q4 25 | $3.9M | $-2.3M | ||
| Q3 25 | $4.9M | $40.1M | ||
| Q2 25 | $4.1M | $23.6M | ||
| Q1 25 | $3.2M | $-37.4M | ||
| Q4 24 | $2.8M | $2.3M | ||
| Q3 24 | $3.5M | $3.6M | ||
| Q2 24 | $3.2M | $-860.0K | ||
| Q1 24 | $3.3M | $-4.2M |
| Q4 25 | 11.7% | 14.3% | ||
| Q3 25 | 17.5% | 61.8% | ||
| Q2 25 | 21.7% | 53.2% | ||
| Q1 25 | 20.1% | -70.7% | ||
| Q4 24 | 17.5% | 34.8% | ||
| Q3 24 | 22.2% | 28.0% | ||
| Q2 24 | 21.1% | 26.5% | ||
| Q1 24 | 22.9% | 14.7% |
| Q4 25 | 8.4% | -4.8% | ||
| Q3 25 | 13.3% | 32.8% | ||
| Q2 25 | 16.3% | 27.7% | ||
| Q1 25 | 14.4% | -90.9% | ||
| Q4 24 | 13.2% | 2.5% | ||
| Q3 24 | 16.6% | 4.0% | ||
| Q2 24 | 16.1% | -0.9% | ||
| Q1 24 | 16.9% | -5.6% |
| Q4 25 | $0.27 | $0.01 | ||
| Q3 25 | $0.34 | $0.23 | ||
| Q2 25 | $0.29 | $0.14 | ||
| Q1 25 | $0.23 | $-0.23 | ||
| Q4 24 | $0.19 | $0.03 | ||
| Q3 24 | $0.25 | $0.02 | ||
| Q2 24 | $0.24 | $-0.01 | ||
| Q1 24 | $0.25 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $163.4M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $193.2M | $-261.8M |
| Total Assets | $977.1M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $163.4M | $215.5M | ||
| Q3 25 | $105.6M | $140.4M | ||
| Q2 25 | $90.1M | $92.9M | ||
| Q1 25 | $120.3M | $108.5M | ||
| Q4 24 | $109.2M | $88.6M | ||
| Q3 24 | $85.8M | $88.2M | ||
| Q2 24 | $89.0M | $105.5M | ||
| Q1 24 | $115.8M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $193.2M | $-261.8M | ||
| Q3 25 | $187.8M | $-264.2M | ||
| Q2 25 | $182.0M | $-308.2M | ||
| Q1 25 | $177.4M | $-334.1M | ||
| Q4 24 | $173.7M | $-301.3M | ||
| Q3 24 | $170.4M | $-311.3M | ||
| Q2 24 | $165.8M | $-321.7M | ||
| Q1 24 | $162.5M | $-330.5M |
| Q4 25 | $977.1M | $396.9M | ||
| Q3 25 | $899.9M | $396.1M | ||
| Q2 25 | $842.5M | $342.9M | ||
| Q1 25 | $804.1M | $327.2M | ||
| Q4 24 | $746.0M | $350.9M | ||
| Q3 24 | $683.0M | $389.5M | ||
| Q2 24 | $617.8M | $395.6M | ||
| Q1 24 | $610.8M | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-28.4M | $74.6M |
| Free Cash FlowOCF − Capex | $-28.6M | $74.6M |
| FCF MarginFCF / Revenue | -61.1% | 156.3% |
| Capex IntensityCapex / Revenue | 0.5% | 0.0% |
| Cash ConversionOCF / Net Profit | -7.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-68.3M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-28.4M | $74.6M | ||
| Q3 25 | $3.5M | $47.6M | ||
| Q2 25 | $-18.3M | $-15.1M | ||
| Q1 25 | $-21.6M | $20.0M | ||
| Q4 24 | $-15.0M | $15.2M | ||
| Q3 24 | $-9.8M | $9.9M | ||
| Q2 24 | $-7.6M | $33.5M | ||
| Q1 24 | $1.8M | $45.0M |
| Q4 25 | $-28.6M | $74.6M | ||
| Q3 25 | $3.4M | $47.6M | ||
| Q2 25 | $-19.8M | $-15.1M | ||
| Q1 25 | $-23.3M | $19.9M | ||
| Q4 24 | $-16.1M | — | ||
| Q3 24 | $-13.4M | $9.9M | ||
| Q2 24 | $-7.7M | $33.4M | ||
| Q1 24 | $568.0K | $44.9M |
| Q4 25 | -61.1% | 156.3% | ||
| Q3 25 | 9.4% | 39.0% | ||
| Q2 25 | -79.0% | -17.7% | ||
| Q1 25 | -105.3% | 48.4% | ||
| Q4 24 | -76.0% | — | ||
| Q3 24 | -64.3% | 10.8% | ||
| Q2 24 | -38.7% | 35.4% | ||
| Q1 24 | 2.9% | 60.0% |
| Q4 25 | 0.5% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 5.8% | 0.0% | ||
| Q1 25 | 7.4% | 0.1% | ||
| Q4 24 | 5.1% | 0.0% | ||
| Q3 24 | 17.2% | 0.0% | ||
| Q2 24 | 0.3% | 0.1% | ||
| Q1 24 | 6.0% | 0.1% |
| Q4 25 | -7.26× | — | ||
| Q3 25 | 0.71× | 1.19× | ||
| Q2 25 | -4.48× | -0.64× | ||
| Q1 25 | -6.78× | — | ||
| Q4 24 | -5.37× | 6.74× | ||
| Q3 24 | -2.84× | 2.71× | ||
| Q2 24 | -2.39× | — | ||
| Q1 24 | 0.53× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
